Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.
about
Ultrasound imaging beyond the vasculature with new generation contrast agentsUltrasound in Radiology: From Anatomic, Functional, Molecular Imaging to Drug Delivery and Image-Guided Therapy.Photoacoustic and Fluorescence Imaging of Cutaneous Squamous Cell Carcinoma in Living Subjects Using a Probe Targeting Integrin αvβ6Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablationTargeted ultrasound contrast agents for ultrasound molecular imaging and therapy.Nanobubbles: a promising efficient tool for therapeutic delivery.Improving performance of nanoscale ultrasound contrast agents using N,N-diethylacrylamide stabilization.Oxygen nanobubbles revert hypoxia by methylation programming.Construction of ultrasonic nanobubbles carrying CAIX polypeptides to target carcinoma cells derived from various organs.Cryo-EM Visualization of Lipid and Polymer-Stabilized Perfluorocarbon Gas Nanobubbles - A Step Towards Nanobubble Mediated Drug Delivery.Acute Inflammatory Response Following Increased Blood-Brain Barrier Permeability Induced by Focused Ultrasound is Dependent on Microbubble Dose.Circulating Magnetic Microbubbles for Localized Real-Time Control of Drug Delivery by Ultrasonography-Guided Magnetic Targeting and Ultrasound.Breaking free from vascular confinement: status and prospects for submicron ultrasound contrast agents.On-chip preparation of nanoscale contrast agents towards high-resolution ultrasound imaging.Carboxyl of Poly(D,L-lactide-co-glycolide) Nanoparticles of Perfluorooctyl Bromide for Ultrasonic Imaging of Tumor.Cavitation-threshold Determination and Rheological-parameters Estimation of Albumin-stabilized Nanobubbles.Oxygen-Carrying Micro/Nanobubbles: Composition, Synthesis Techniques and Potential Prospects in Photo-Triggered Theranostics
P2860
Q27691825-4DC3CC3B-2620-4979-8ED8-1C65AE658027Q30278971-D68116F7-38EB-4DF8-B267-EFD7D0F2105CQ30363423-AB3FEDC2-288F-4D5E-8B38-BBEC4E98470EQ30410530-AC7F7C12-60AE-407F-8C12-876623414784Q38364441-CB50FB7A-176B-4946-AAFF-916963266861Q38697378-313089AB-C93B-4885-997E-361409E5FB52Q38827418-3A4160CE-920A-4E02-8EAF-C63D0A7A6209Q41516085-8EEB6990-9CB6-49B7-9DD8-46D20A0DCF82Q42233933-85421B77-C1ED-411E-A636-A4DBF671B1EBQ42658769-7CA31A73-EDA2-4DE4-B907-1DF1A5741589Q43693994-358688F3-83B9-4724-AABE-325A4E889EEFQ47135019-FC33D1B4-80A5-4321-8A8E-3B074D1D261AQ49931358-F44039AF-E491-4386-A908-CDD32AB2CE00Q51473926-4A600CF7-2AE6-4891-B81A-996A1772AA51Q55223774-A8C56A8A-8B10-4C93-9858-BA982B237496Q55438529-C7C2F6AF-9568-4AA3-B612-1D7A0AD5412DQ58696312-BF06C0BC-E359-4B35-BA6E-DF131E0CC13A
P2860
Acoustic characterization and pharmacokinetic analyses of new nanobubble ultrasound contrast agents.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Acoustic characterization and ...... le ultrasound contrast agents.
@ast
Acoustic characterization and ...... le ultrasound contrast agents.
@en
type
label
Acoustic characterization and ...... le ultrasound contrast agents.
@ast
Acoustic characterization and ...... le ultrasound contrast agents.
@en
prefLabel
Acoustic characterization and ...... le ultrasound contrast agents.
@ast
Acoustic characterization and ...... le ultrasound contrast agents.
@en
P2093
P2860
P1476
Acoustic characterization and ...... le ultrasound contrast agents.
@en
P2093
Christopher Sanders
Gilles Guenette
Hanping Wu
Hiroki Yoshiara
Luis Solorio
Naohisa Kamiyama
Nicolas G Rognin
Tianyi M Krupka
P2860
P304
P356
10.1016/J.ULTRASMEDBIO.2013.05.007
P577
2013-08-09T00:00:00Z